SARAF
Store-operated calcium entry-associated regulatory factor
Also known as: MGC8721, SARAF_HUMAN, TMEM66
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96BY9
- Gene
- SARAF
- Ensembl
- ENSG00000133872
- Chromosome
- 8
- Canonical length
- 339 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum,Rods & Rings
OverviewNCBI Gene
Involved in regulation of store-operated calcium entry. Located in endoplasmic reticulum membrane and endoplasmic reticulum-plasma membrane contact site. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
339 residues, UniProt reviewed canonical sequence.
>Q96BY9|SARAF
1 MAAACGPGAA GYCLLLGLHL FLLTAGPALG WNDPDRMLLR DVKALTLHYD RYTTSRRLDP
61 IPQLKCVGGT AGCDSYTPKV IQCQNKGWDG YDVQWECKTD LDIAYKFGKT VVSCEGYESS
121 EDQYVLRGSC GLEYNLDYTE LGLQKLKESG KQHGFASFSD YYYKWSSADS CNMSGLITIV
181 VLLGIAFVVY KLFLSDGQYS PPPYSEYPPF SHRYQRFTNS AGPPPPGFKS EFTGPQNTGH
241 GATSGFGSAF TGQQGYENSG PGFWTGLGTG GILGYLFGSN RAATPFSDSW YYPSYPPSYP
301 GTWNRAYSPL HGGSGSYSVC SNSDTKTRTA SGYGGTRRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SARAF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 386 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 386 nTPM
- cerebral cortex: 304 nTPM
- hypothalamus: 299 nTPM
- placenta: 291 nTPM
- liver: 283 nTPM
- choroid plexus: 282 nTPM
Single-cell type
- late spermatids: 1,496 nCPM
- t-cells: 1,185 nCPM
- epididymal principal cells: 914 nCPM
- early spermatids: 722 nCPM
- mast cells: 661 nCPM
- innate lymphoid cells: 656 nCPM
Immune cell
- basophil: 969 nTPM
- total PBMC: 925 nTPM
- naive CD4 T-cell: 779 nTPM
- naive CD8 T-cell: 546 nTPM
- T-reg: 485 nTPM
- neutrophil: 481 nTPM
Brain region
- hypothalamus: 538 nTPM
- midbrain: 438 nTPM
- pons: 415 nTPM
- cerebral cortex: 374 nTPM
- hippocampal formation: 366 nTPM
- basal ganglia: 359 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Store-operated calcium entry-associated regulatory factor
- SOCE-associated regulatory factor of calcium homoeostasis
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SARAF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SARAF as an antibody target. Whether an autoantibody or antibody against SARAF could matter depends on whether native SARAF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SARAF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SARAF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...